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INTRODUCTION

An enzyme system present in a variety of mammalian organs catalyzes
the binding of amines to proteins (2, 3). According to our present knowledge, the -reaction may be expressed as follows:
protein

+

amine

ca++
-----4

enzyme

amine-protein

+

NHa .

As shown previously, the amine is bound in covalent linkage to the acceptor
protein. A variety of primary amines, among them lysine and glycinamide
as well as hydroxylamine and ammonia, are incorporated into the acceptor
protein, in this Ca++-activated enzymic reaction.
Not only proteins occurring in tissue extracts but also a number of purified proteins, such as casein, pepsin, or ,8-lactoglobulin, may serve as amine
acceptors; whereas others, such as bovine serum albumin or ')'-globulin incorporate only insignificant quantities of amine. It is of considerable interest to determine why amine acceptor activity is confined to only some
proteins. Since strong indication had been obtained that the enzyme catalyzes the exchange of the amide group of protein-bound glutamine with
the amine (4), the properties of the protein as amine acceptor may be
determined by the amino acid sequence around an active glutamine residue.
It has already been reported that zinc-free insulin is one of the most active
This work was supported by grants from the National Institute of Neurological
Diseases and Blindness (Grant B-557) and from the Ford Foundation and by a contract between the Office of Naval Research and the Psychiatric Institute. Presented
in part before the 43rd Annual Meeting of the American Society of Biological Chemists in Atlantic City, New Jersey, April13- 17, 1958 (1).
2 We are indebted to Dr. Otto K. Behrens of Eli Lilly and Co. for the generous
gifts of crystalline bovine insulin employed in this investigation.
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amine-accepting substrates (4). This protein, with its known amino acid
sequence (5) containing six amide groups (three glutamine and three asparagine residues), appeared to be an ideal substrate for a more detailed
study of the mechanism of the amine incorporation reaction. Such an investigation could serve to generalize the results previously obtained with
casein that protein-bound glutamine is the active site of amine incorporation. An answer as to whether or not all three glutamine residues participate
equally in the enzymic reaction would pave the way to our understanding
of the significance of the amino acid sequence around an active glutamine
residue and ultimately to the synthesis of suitable substrates.
The investigation of the amine-incorporating reaction has been carried
out with the aid of C14-labeled amines or N 15-labeled ammonia. In the
present study, hydroxylamine also was used as the replacing amine since
the hydroxamate formed from an acid-soluble substrate could be measured
directly as the ferric chloride complex. When acid-insoluble substrates were
used, the bound hydroxylamine could be determined after hydrolysis of
the protein.
It had been reported previously that ammonia is evolved during the
amine incorporation reaction, a fact which first directed our attention to
the possibility of the protein-bound amides as active sites. The quantity of
ammonia evolved was usually in excess of the quantity of amine incorporated. Furthermore, even in the absence of an added amine, ammonia is
evolved under the conditions necessary for amine incorporation. This
finding led to the suggestion, supported by observation on casein as substrate, that, in the absence of added amine, the €-amino group of proteinbound lysine can act as the replacing agent (4). Experiments to determine
the extent of the participation of lysine in cross-linking reactions with
insulin as substrate are also included in this paper.
METHODS

•

Enzyme. The enzyme employed in these studies was the guinea pig liver preparation described previously (3).
Zinc -Free Insulin. Crystalline beef zinc- insulin (1 g.) was suspended in 20 ml. of
cold water. Sodium hydroxide (6 N) was added dropwise until solution was effected.
The solution was then adjusted to pH 8 and dialyzed in the cold room overnight
against two changes of 7 I. each of 0.001 M sodium ethylenediamine tetracetate (pH
ca. 7.5).

Separation of the A and B Chains of Insulin
After performic acid oxidation of 1 g. insulin (6), the reaction mixture was evaporated to a thin sirup in a rotary vacuum evaporator. The sirup was dissolved in 10
ml. of 50% formic acid and placed on a column (30 X 0.9 em.) of Dowex 50 X 4 (100
mesh) in the H+ form which had been washed with 20 ml. of 50% formic acid. The A

530

MYCEK, CLARKE, NEIDLE AND WAELSCH

chain was then eluted with water. It emerged with the solvent front as detected by
measurement of the absorption at 270 m,u.
Following the elution of the A chain, the column was washed with water until the
effluent had a pH near neutrality. Ammonium hydroxide (1 N) was then used to
displace the B chain.
The fractions containing A and B chain, respectively, were concentrated to a small
volume in vacuo, precipitated with acetone, and washed. Yield (A chain): 360 mg.
(81 %) . Yield (B chain): 450 mg. (74%).
The basic amino acids, present in insulin only in the B chain, were not detected
on two-dimensional paper chromatography (7) of the 6 N HCl hydrolyzate of these
A chain preparations.

Determination of the Incorporation of Labeled A mines into Insulin
The incubation conditions are given in the legends to the tables and figures. At
the end of the incubation period, insulin was precipitated by adding 50% trichloroacetic acid (TCA) to a final concentration of 5% . The precipitated protein was washed
repeatedly with 5% TCA and then dissolved in a minimal amount of absolute ethanol
and reprecipitated with ether. The methods for the determination of radioactivity
and amide N 15 content of the recovered protein have been described (3). The quantity
of amine incorporated (,umoles/,umole insulin) was calculated from the specific activities of the protein and the entering amine both measured at infinite thickness.

Hydroxylamine Incorporation
The extent of hydroxylamine incorporation into the A chain of insulin can be
measured directly by the color reaction of the hydroxamate formed (8). An A chain
sample of known hydroxamic acid content was employed as a standard. In order to
obtain this material, insulin A chain following incubation with hydroxylamine and
enzyme was conveniently freed of the unreacted base by passage of the reaction
mixture through a short column of Dowex 50 X 4 in the H+ form. The absolute hydroxylamine content of this A chain was then determined after acid hydrolysis by
the method of Csaky (9). By comparing this value with that obtained from the FeCl 3
procedure, it was found that A chain-bound glutamohydroxamic acid had a color
equivalent 1.2 times that of free glutamohydroxamic acid.

Determination of N 15 Distribution
Insulin, containing 8.45 atom% excess N 15 in the amide nitrogen, was prepared
enzymically by utilizing ammonia-N 16 (61 atom% excess) as the replacing amine.
The labeled insulin (350 mg.) was incubated with 40 mg. each of Pan-protease and
Peptidase (Worthington Biochemical Corp.), in 45 ml. of 0.02 M phosphate buffer
(pH 8.0) with 1 mmole sodium thioglycolate at 38°0. for 48 hr. in the presence of a
few drops of toluene as a preservative. After incubation, amino nitrogen determination (10) indicated about 50% hydrolysis. The incubation mixture was dialyzed in
the cold room against two changes of 300 mi. water. The dialyzate was concentrated
in vacuo to 5 mi. and mixed with an equal volume of 0.2 N sodium acetate buffer pH
3.45 and placed on a 100 X 4 em. column of Dowex 50 X 8 which had been equilibrated
with the same buffer. Aliquots of the effluent fractions were analyzed by t he ninhydrin procedure of Moore and Stein (11), and by treatment with half-saturated KOH
in the Conway microdiffusion apparatus to locate glutamine and asparagine (12).
The fractions yielding ammonia were combined and subjected to precipitation with
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mercuric nitrate (13). The mercury complex was resuspended in water and decomposed with H 2S. The mercuric sulfide was removed by centrifugation and washed
with several portions of water. The supernatant fluid and washings were combined,
concentrated, streaked on Whatman No. 1 filter paper, and chromatographed in a
solvent system of butanol- formic acid- water (8: 1: 2) (7). The bands corresponding
to glutamine and asparagine were eluted and concentrated. Treatment of the two
concentrates with half-saturated KOH in Conway microdiffusion vessels released
the amide ammonia which could then be analyzed for N 15 content in the mass spectrometer.
A minor modification of this method in which the glutamine and asparagine amide
N were recovered by differential hydrolysis of the unresolved amide fraction was
applied previously to localization of the ammonia-N 15 incorporated into casein (4).

Determination of Lysine Bound by Its e-Amino Group
The protein (40- 50 mg.) obtained after enzymic incubation and washed in the
usual manner was dissolved in 1 ml. of 90% acetic acid and 2 ml. of 50% potassium
nitrite solution added dropwise with periodic stirring during the course of 2 hr. The
reaction mixture was diluted to 5 ml., and 5 ml. of 10% TCA was added . The precipitated protein was separated by centrifugation and washed with 5% TCA until the
washings were free of nitrite (starch- iodide test). The protein was then washed with
ethanol-ether (1:5) and then with ether, and finally dried in a vacuum desiccator.
The dried material was redissolved in 1 ml. of 90% acetic acid, and the deamination
procedure was repeated .
Weighed samples of the protein which had been subjected twice to deamination
and 2 ml. of 6 N HCl were placed in sealed tubes and heated at 100°C. for 16 hr. The
hydrolyzates were taken to dryness, dissolved in water, neutralized, decolorized
with activated charcoal, and made up to 5 ml. Aliquots were taken for determination
of lysine by the microbiological procedure of Henderson and Snell (14).
c:-Hydroxy-a -amino caproic acid neither replaced lysine nor acted as an antagonist
of the amino acid in the microbiological assay. When the deamination procedure was
performed on insulin which had been incubated with enzyme in the absence of Ca++,
about 3% of the total lysine content was recovered in the microbiological assay. The
experimental values were corrected accordingly. The determination by this method
of the extent of lysine cross-linking using casein as a substrate has been reported (4).
•

RESULTS AND DISCUSSION

Substrate Properties of Insulin

The incorporation of a variety of primary amines into zinc-free insulin,
in the presence of calcium, is catalyzed by the same protein fraction which
has been shown to incorporate amines into other proteins (3) (Table I).
Insulin is unique among the proteins tested as substrates in having an
absolute requirement for reducing agents (Table I), while amine incorporation into other protein substrates proceeds to an appreciable extent even
in the absence of added reducing agents. The effective reducing agents
tested include thioglycolate, thioethanol, glutathione, and sodium borohydride (Fig. 1).
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TABLE I
The Incorporation of A mines into Insulin
Complete system contained: insulin, 15 mg.; amine-C 14 (specific activity approx.
0.05 ,uc./,umole or ammonia-N 15 (32 N 15 atom % excess), 10 ,umoles; GSH, 100 ,umoles;
CaCh, 5,umoles; Tris buffer, 40,umoles, pH 8.0; enzyme, 1 mg. protein. Total volume:
2.0 ml. Incubated at 38°C. for 1 hr.
Amine
Insulin

Amine

1-'moles/ 1-'mole

Cadaverine, complete system
Cadaverine, minus Ca++
Cadaverine, minus GSH
Cadaverine, minus enzyme
Putrescine, complete system
Methylamine, complete system
Histamine, complete system
Ammonia, complete system

c:

0.98
0.03
0.01
0.00
1.10
1.10
1.20
1.20

1.2

;:)
II)

c:

'+-

0

1.0

Q)

0

E

::t.

....
Q)

0.8

a.
Q)

c:
u

0.6

II)

Q)

....

+-

;:)

a.
'+-

0

0.4

II)

Q)

0

E
::t.

0.2

10

20

30

Glutathione

40

50

p.moles

ML.

FrG. 1. The dependence of amine incorporation into insulin on glutathione. The
conditions were the same as those in Table I except that the amine employed was
putrescine-C 14 (0.015 ,uc./ ,umole) and the glutathione concentration was varied.
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Previous evidence suggests that the incorporation of ammonia into
casein is the result of the displacement of the amide groups of proteinbound glutamine (4). If a similar mechanism is operative for the incorporation of ammonia-N 15 into insulin, then glutamine-N15 should be recoverable
from an enzymic hydrolyzate of the labeled insulin (amide nitrogen =
8.45 N 15 atom % excess). When both glutamine and asparagine were recovered from such an experiment, the label was found to be present exclusively in the glutamine amide nitrogen (10.85 N 15 atom % excess;
asparagine amide nitrogen = 0.05 N 15 atom %excess). It should be noted
that the value for the atom % excess N 15 (10.85) was lower than that expected (2 X 8.45) on the basis of the atom % excess N 15 in the total
amide nitrogen of insulin. This result is probably explained by the fact
that there is an unequal release of the three glutamine residues in the
course of the proteolytic digestion. However, these considerations do not
affect the results, namely, that only the isolated glutamine is labeled. Thus,
for both insulin and casein, the incorporation of amines leads to proteins
with modified glutaminyl amide groups.
Of the three glutamine residues present in insulin, two are in the A chain
and one is in the B chain. Insulin, enzymically labeled with ammonia-N15
or methylamine-C14 was subjected to performic acid oxidation. The distribution of label in the isolated A and B chains was determined: 97 and 98%
of the respective bases were found in the A chain (Table II).
After oxidation of insulin, the isolated A and B chains obtained were
individually tested for substrate activity with hydroxylamine as the replacing amine (Table III). The A chain incorporated hydroxylamine equivalent
to 1.3 .Mmoles/ J..tmole of A chain; however, B chain showed hardly any
substrate activity. It should be noted that, under the experimental conditions used, A chain did not require the presence of a sulfhydryl compound
for full activity as a substrate.
TABLE II
Distribution of Label after Amine Incorporation into Insulin
Conditions of incubation were the same as those in Table I.
Amine incorporated

Insulin
A chain
B chain

Methylamine- C14

Ammonia-N1 5

p.molesj p.mole

p.molesj p.mole

0.96
0.92
0.02

0.70
0.70
0.02
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TABLE III
The Incorporation of Hydroxylamine into Isolated A and B Chains
Each tube contained: 2 mg. of either A or B chain; GSH, 10 J.Lmoles; CaCl2,
5 J.Lmoles; Tris buffer, 40 J.Lmoles, pH 8.0; NH20H, 100 J.Lmoles; enzyme, 1 mg. protein. Total volume: 2 ml. Incubated at 38°C. for 1 hr.
Hydroxama te
A chain
p.molesfl.~,mole

A
A
A
B

Chain
chain minus GSH
chain minus GSH plus insulin (10 mg.)
chain

1.34a
1.28
0 . 12
0.10

With other A chain preparations, values of 1.95, 1.70, 1.40, and 1.28 J.Lmoles hydroxylamine/ J.Lmole A chain were found.
a

A study of the extent of hydroxylamine incorporation into A chain as a
function of amine concentration showed this amine to be a very efficient
replacement agent (Fig. 2). At low concentrations of hydroxylamine, 80%
of the added amine was bound.
The Extent of Amide Replacement

In the experiments reported, hydroxylamine incorporation into A chain
varied from 1.3 to 2.0 equiv. / mole of A chain (cf. Fig. 2 and Table III).
Therefore, it appears that both glutamine residue present in the A chain
can participate in the exchange reaction.
Somewhat lower values were found for the incorporation of amines into
insulin (cf. Table I). However, an independent measure of the number of
reactive sites in the insulin molecule can be obtained from the specific
activity of the ammonia released when insulin enzymically labeled with
ammonia-N15 is reincubated with enzyme in the presence of an amine.
Insulin enzymically labeled with ammonia-N 15 (32 atom % excess) contained 6.33 N 15 atom %excess in its amide groups. When this insulin was
reincubated with cadaverine, under the conditions described in Table I,
the ammonia liberated contained 15.34 N 15 atom % excess. The calculated
value for the N 15 atom % excess in the ammonia released if two reactive
sites are present is 19.0. In a second experiment with an insulin sample
having 6.90 N 15 atom % excess in the amide nitrogen, ammonia of 23.31
N 15 atom % excess was released on reincubation with cadaverine. Since
the ammonia liberated had close to three times the specific activity of that
of the total amide nitrogen of insulin, two of the six amide groups of insulin must be available for the exchange reaction.
Reversibility. The foregoing experiment indicates that the exchange of
ammonia with the reactive glutamine amide groups of insulin is freely
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E
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I

I

I

I

I

5
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.
J.Lmoles
Hydroxylamine
ML.

2. The incorporation of hydroxylamine into A chain. The conditions of incubation were those of Table III except that the hydroxylamine concentration was
varied.
FIG.

reversible. In addition, putrescine bound to insulin could be displaced by
ammonia, hydroxylamine, histamine, and cadaverine.
Ammonia Release and A mine Incorporation

..

In Fig. 3, the quantities of ammonia released from insulin in the presence
and absence of cadaverine are shown as a function of pH. At pH values of
8 and above, since all the ammonia formed during the reaction can be
accounted for by the cadaverine incorporated, the amine-independent
ammonia-liberating reaction is suppressed, thus suggesting that both
reactions compete for common sites on the insulin molecule.
For casein, it has been shown that much of the amine-independent
ammonia release results from a cross-linking reaction involving the €-amino
groups of protein-bound lysine (4). However, with insulin as substrate, at
most 25% of the amine-independent reaction can be accounted for in this
way (Fig. 4). It is of interest that amine-independent ammonia liberation
can be observed also with A chain, a substrate which contains no lysine.
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1.0

0.9

•

0.8
c
:l

0.7

If)

c

......
0

C1)

0.6

0

E
:t
'-

C1)

0.5

n

If)

C1)

0

E
:t

0.4

0.3

0.2

0.1

+
5

6

7

8

9

pH

3. Ammonia liberation and cadaverine incorporation as a function of pH
Conditions as in Table I. At end of incubation, TCA was added to each tube, and
the precipitated insulin was counted at infinite thickness, the supernatant fluids were
neutralized, and aliquots were taken for ammonia determination (15). Ammonia
liberation in the absence of added amine (+); ammonia release in the presence of
added amine ( 0); cadaverine incorporated (e ).
FIG.

GENERAL CoNSIDERATIONs

The experiments presented in this report establish that the A chain acts
as the amine-accepting moiety of insulin in the enzymically catalyzed
amine incorporation reaction. Not only is no amine incorporated into B
chain with whole insulin as substrate, but also when employed separately
the B chain proves to be inert. The necessity of adding sulfhydryl compounds to experiments with whole insulin as substrate suggests that some
of the disulfide linkages between the two chains have been reduced and
that the substrate was not the intact protein. Without added sulfhydryl
compounds, insulin appears to inactivate the enzyme which has been shown
previously to be inhibited by reagents which react with sulfhydryl groups.
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FrG. 4. The ammonia liberation and cross-linking involving the «:-amino group o
protein-bound lysine as a function of pH. The conditions are the same as those in
Fig. 3, except that an amine was not present. Ammonia release in the absence of
added amine (+); micromoles of lysine recovered after deamination of the protein
( 0). (See Methods.)

In keeping with these observations, the A chain can serve as a substrate
without the addition of a reducing agent. It is of interest that the presence of weakly acidic sulfhydryl groups or strongly acidic sulfonic acid
groups does not interfere with the ability of insulin or the A chain, respectively, to serve as substrate.
Before the characteristics of insulin as substrate were known in detail,
insulin samples, after incubation with various amines, were tested for
physiological activity through the courtesy of Dr. Otto Behrens in the
laboratories of Eli Lilly and Co. The various insulin samples had lost most
of their activity, an observation understandable if a splitting of its disulfide
groups by added reducing agents were to precede or accompany incorporation of the amine (16).
In insulin as well as in casein, N 15H 3 was found to replace the amide
groups of the glutamine residues but not those of asparagine. No direct
evidence has been obtained that amines other than ammonia also replace
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the amide groups of glutamine. However, that this is the case is strongly
suggested by the fact that these amines displace ammonia-N 15 from enzymically labeled insulin upon reincubation with enzyme, calcium, and the
respective amine. The incorporation of amine approaching 2 equiv./ mole
of A chain indicates that the amide groups of both glutamine residues are
replaceable.
In order to clarify the question as to whether or not the amino acid
sequence around a given glutamine residue is necessary as a whole or in part
for substrate activity, a synthesis of the corresponding peptides is under
way. In preliminary experiments, oxytocin, vasopressin, corticotropin, and
ribonuclease and a number of glutamine peptides3 were tested-all with
negative results. On the other hand, enzymic casein hydrolyzates showed
considerable substrate activity.
With insulin as substrate, the ammonia release in the absence of added
amine can only be accounted for partially by cross-linking with the €-amino
groups of lysine. This may be due to the fact that the lysine content of
insulin (2.5 %) is lower than that of casein for which most of the ammonia
liberation under these conditions could be attributed to cross-linking with
lysine. The particular significance of these results is that it underlines the
need for additional mechanisms to explain ammonia release in the absence
of amine. Studies are in progress to determine whether a hydrolytic reaction or a displacement involving the amino groups of N-terminal amino
acids accounts for this lack of stoichiometry.
There is now evidence that the amine-incorporating enzyme catalyzes
an exchange reaction between a wide variety of amines and the amide
ammonia of certain glutamine residues in peptide linkage. The conditions
for the activity of this enzyme are obviously different from those for the
glutamotransferase found in mammalian tissues (17). However, the reaction does have some resemblance to that catalyzed by the bacterial glutamotransferase enzyme (18); that is, the )'-amide of protein-bound glutamine
in the former instance and free glutamine in the latter is replaced by a
nucleophilic agent to form a new amide bond and ammonia. Though the
specificity for the )'-amide group of glutamine appears to be the same, the
bacterial glutamotransferase is not capable of incorporating amines into
proteins, nor can the amine-incorporating enzyme catalyze the formation
of glutamohydroxamic acid from glutamine and hydroxylamine (3). In
addition, calcium is an obligatory factor for the amine-incorporating
activity, but it has no influence on the activity of the bacterial transferase
We wish to acknowledge the gifts of vasopressin and oxytocin from Dr. D. A.
McGinty of Parke, Davis and Co., of corticotropin A from Dr. W. F. White of Armour
and Co., of .a-corticotropin from Dr. C. E. Graham of The Wilson Laboratories, of
ribonuclease from Dr. W. H. Stein of The Rockefeller Institute, and of a variety of
glutamine peptides from Dr. Klaus Hoffman of the University of Pittsburgh.
3

,

TRANSGLUTAMINASE ACTION ON INSULIN

•

539

(18). Reducing agents or sulfhydryl inhibitors have no apparent effect on
the bacterial enzyme (18), in contrast to the amine-incorporating enzyme.
Since it would be convenient to refer to the amine-incorporating system
by name, we propose to call this enzyme activity, transglutaminase. Thus,
transglutaminase describes the activity of an enzyme system which catalyzes the exchange of amide groups of peptide-bound glutamine with a
variety of compounds containing a primary amino group to yield new
'Y-amide bonds, and ammonia .
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SUMMARY

•

Since insulin serves as an excellent substrate in the enzymically catalyzed
amine incorporation reaction, a detailed study of its substrate properties
was undertaken. A method for the separation of the A and B chains of
oxidized insulin employing Dowex 50 resin is described.
Native zinc-free insulin inhibited the enzyme, an inhibition which could
be overcome by the addition of glutathione or other reducing agents.
The mechanism of the reaction with insulin as substrate involves a
replacement of the amide groups of peptide-bound glutamine but not of
asparagine by the amine. The incorporated amines (N15H 3 , methylamine,
hydroxylamine) are localized solely in the A chain of insulin. Isolated A
chain but not B chain can serve as an amine acceptor.
The use of hydroxylamine as a replacing amine permits the measurement
of the reactivity of acid-soluble peptides and proteins readily by determining the extent of hydroxylamine incorporation calorimetrically.
In the presence of added amine, the ammonia equivalents released correspond to those of amine incorporated at the pH optimum. In the absence
of added amine, cross-linking of the protein-bound lysine accounted only
for a small portion of the liberated ammonia.
The name transglutaminase is sugge ted for the enzymic activity catalyzing amine incorporation .
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